|
市場調査レポート
商品コード
1374407
超音波トランスデューサの世界市場規模、シェア、産業動向分析レポート:製品タイプ別、最終用途別、地域別展望と予測、2023年~2030年Global Ultrasound Transducer Market Size, Share & Industry Trends Analysis Report By Product Type, By End Use (Hospital, Clinic, Diagnostic Center, and ASCs), By Application, By Regional Outlook and Forecast, 2023 - 2030 |
||||||
|
超音波トランスデューサの世界市場規模、シェア、産業動向分析レポート:製品タイプ別、最終用途別、地域別展望と予測、2023年~2030年 |
出版日: 2023年09月30日
発行: KBV Research
ページ情報: 英文 434 Pages
納期: 即納可能
![]() |
世界の超音波トランスデューサの市場規模は、予測期間中にCAGR 3.6%で成長し、2030年までには49億米ドルに達すると予測されます。2022年の市場規模は193万3,900台、成長率は4.0%(2019-2022年)を遂げています。
KBV Cardinal matrixに示された分析によると、Samsung Electronics Co.(Samsung Group)(Samsung Medison Co., Ltd.)は、2020年10月、新しい超音波システムHERA W10と椅子型超音波システムHERA I10のプロトタイプを発売し、新しいレベルの画質で改善された技術と製品を提供します。GE HealthCare Technologies, Inc.、Shenzhen Mindray Bio-Medical Electronics Co., Ltd.、Hitachi, Ltd. (Hitachi Healthcare)などの企業が市場における主要なイノベーターです。
COVID-19影響分析
超音波トランスデューサは、パンデミックの間、特にCOVID-19患者の評価において重要な役割を果たしました。ベッドサイド超音波(ポイント・オブ・ケア超音波、POCUS)は、集中治療室(ICU)や救急部におけるCOVID-19患者の肺の状態、心機能、血管アクセスのモニタリングに広く使用されました。パンデミックは、迅速な診断と患者管理のための貴重なツールとして、ポイントオブケア超音波(POCUS)の採用を加速させました。ヘルスケアプロバイダーは、被ばくを最小限に抑え、患者ケアを向上させるために、高出力のシングルユーストランスデューサを含むハンドヘルド超音波診断装置に注目しました。ヘルスケアシステムや施設は、将来の健康上の緊急事態に対応するために、超音波トランスデューサのような、すぐに利用でき、持ち運び可能で、汎用性の高い画像診断ツールを持つことを重視しています。結論として、COVID-19パンデミックは市場に短期的な混乱と長期的な変革効果をもたらしました。
市場成長要因
先端医療機器への投資
ヘルスケア支出の増加は、超音波トランスデューサの需要拡大の大きな原動力です。ヘルスケア支出には、政府、医療機関、保険会社、個人がヘルスケアサービスを提供し、利用するために行う投資が含まれます。ヘルスケア支出の増加により、医療機関や施設は超音波装置やトランスデューサを含む先進医療機器の調達に予算を割り当てることができます。こうした投資は、ヘルスケアのインフラを近代化し、提供されるケアの質を向上させることを目的としています。医療費の増加は、母子保健サービスに向けられており、超音波検査は、出産前のケア、胎児の発育のモニタリング、母体の健康状態を評価するための基本的なツールです。このような女性と子供の健康への注目は需要を促進します。
超音波画像に対する意識の高まり
超音波画像診断の利点に対する意識の高まりは、超音波の臨床応用の頻度と多様性を高め、患者ケアと医学的意思決定の形成に極めて重要な役割を果たしています。非侵襲性と安全性は、超音波トランスデューサをヘルスケアにおける好ましい診断ツールとする2つの重要な特性です。これらの特質が、超音波画像診断が広く採用され、患者に受け入れられる要因となっています。超音波画像診断は完全に非侵襲的であり、器具の挿入や電離放射線の使用を必要としません。この非侵襲性により、外科的切開が不要となり、関連するリスクや合併症が軽減されます。超音波検査では、人によってはアレルギー反応を引き起こす可能性のある造影剤を使用する必要がありません。このため、特に造影剤に対するアレルギーが知られている患者にとっては安全性が高まります。これらすべてが、今後数年間の市場拡大の大きな原動力となると思われます。
市場抑制要因
高度なトランスデューサに関連する高額な初期費用
新興諸国は先進諸国に比べて財源が限られており、一人当たりの所得も低いことが多いです。高度な超音波装置の初期費用が高額になると、ヘルスケア予算が圧迫され、医療機関がそのような技術に投資することが難しくなります。発展途上地域のヘルスケア・インフラは未発達であったり、設備が不十分であったりします。高価な画像診断機器に予算の大部分を割くことは、他の差し迫ったヘルスケアの優先事項とのトレードオフとみなされる可能性があります。発展途上地域は、スペアパーツやテクニカルサポートの利用可能性など、高価な機器の長期的な持続可能性に懸念を持つことがあり、初期費用の高い先端技術への投資に消極的になることがあります。こうした要素は、超音波トランスデューサ市場の今後の拡大を困難にすると思われます。
製品タイプの展望
製品タイプ別に見ると、リニア、コンベックス、フェーズドアレイ、エンドキャビティ、CWドップラー、その他に分けられます。フェーズドアレイセグメントは、2022年の市場で顕著な収益シェアを獲得しました。フェーズドアレイ変換器は、心臓イメージング、特に心エコー検査に不可欠です。超音波ビームを電子的に制御する能力により、心臓構造を正確に可視化し、心臓機能をリアルタイムで評価することができます。心血管疾患(CVD)の増加に伴い、心臓超音波の需要は大きく伸びています。血管超音波は、フェーズドアレイ・トランスデューサを利用して、動脈や静脈などの血管を可視化します。
最終用途の展望
最終用途別では、市場は病院、クリニック、診断センター、外来手術センター(ASC)に区分されます。2022年には、診療所セグメントが市場で大きな収益シェアを獲得しました。診療所は予防医学と健康診断を重視しています。超音波トランスデューサは、乳がん、甲状腺疾患、腹部疾患などのスクリーニングを可能にし、早期発見と介入を可能にすることで、予防医療に重要な役割を果たしています。外来患者の臨床医は、患者ケアを強化するためにポイントオブケア超音波(POCUS)を採用することが増えています。
用途の展望
用途別に見ると、市場は心臓血管、一般画像、筋骨格系、産婦人科、血管、その他に区分されます。OB/GYNセグメントは、2022年の市場で大きな収益シェアを獲得しました。産婦人科用超音波トランスデューサは、ヘルスケアプロバイダが妊娠期間を通して胎児の発育をモニターできるようにし、出産前ケアに役立っています。胎児の成長を評価し、異常を検出し、赤ちゃんの位置を決定し、胎盤を評価します。妊婦の両親は、超音波検査によって胎児を視覚化し、絆を深めることができます。出産時の母親の年齢が高くなるにつれて、特定の合併症のリスクも高くなります。ハイリスク妊娠では、超音波検査を含むより頻繁で高度な出生前モニタリングが必要となることが多いです。
地域の展望
地域別に見ると、市場は北米、欧州、アジア太平洋、ラテンアメリカ、中東、アフリカに分けられます。北米セグメントは、2022年の市場で最も高い収益シェアを記録しました。北米は、最先端の医療施設、病院、クリニック、診断センターなど、高度なヘルスケアインフラを誇っています。このインフラは、質の高い患者ケアをサポートするために、超音波トランスデューサのような先進医療技術に対する旺盛な需要を生み出しています。この地域は、心血管疾患、糖尿病、肥満などの慢性疾患の有病率が比較的高いです。超音波トランスデューサは、これらの慢性疾患の診断、モニタリング、管理に不可欠であり、需要の拡大に寄与しています。これらすべての要因が、今後の北米セグメントの拡大を後押しすると思われます。
The Global Ultrasound Transducer Market size is expected to reach $4.9 billion by 2030, rising at a market growth of 3.6% CAGR during the forecast period. In the year 2022, the market attained a volume of 1,933.9 thousand units, experiencing a growth of 4.0% (2019-2022).
The demand for routine diagnostic imaging remains steady due to its essential role in healthcare. Consequently, the General Imaging segment registered a $1,329.6 million revenue in the market in 2022. General imaging transducers are ideal for routine diagnostic examinations. They are commonly used for general health assessments, such as evaluating abdominal organs, assessing the female reproductive system, and monitoring the progression of pregnancies. They are used to detect conditions like breast cancer, prostate cancer, and thyroid disorders early. The increasing emphasis on preventative healthcare drives the demand for these transducers. Therefore, the general imaging segment has the potential for high growth in the future.
The major strategies followed by the market participants are Product Launches as the key developmental strategy to keep pace with the changing demands of end users. For instance In July, 2022, GE HealthCare Technologies, Inc. released Voluson Expert 22, the most advanced ultrasound yet. The launched product would produce the best quality images and would provide greater flexibility in imaging functions. Additionally, In September, 2022, FUJIFILM Sonosite Inc. launched Sonosite LX system in several European countries, to support clinicians in using transoesophageal ultrasound at the point of care, both of which are created to be used with the Sonosite LX and Sonosite PX.
Based on the Analysis presented in the KBV Cardinal matrix; Samsung Electronics Co., Ltd. (Samsung Group) (Samsung Medison Co., Ltd.) is the major forerunner in the Market. In October, 2020, Samsung Medison launched a new ultrasound system HERA W10 and prototype of a chair-type ultrasound system HERA I10, to deliver improved technology and offerings with a new level of image quality. Companies such as GE HealthCare Technologies, Inc., Shenzhen Mindray Bio-Medical Electronics Co., Ltd., and Hitachi, Ltd. (Hitachi Healthcare) are some of the key innovators in Market.
COVID-19 Impact Analysis
Ultrasound transducers were crucial in critical care settings during the pandemic, especially in assessing COVID-19 patients. Bedside ultrasound (point-of-care ultrasound or POCUS) was widely used to monitor lung conditions, cardiac function, and vascular access in COVID-19 patients in intensive care units (ICUs) and emergency departments. The pandemic accelerated the adoption of point-of-care ultrasound (POCUS) as a valuable tool for rapid diagnostics and patient management. Healthcare providers turned to handheld ultrasound devices, including high-powered, single-use transducers, to minimize exposure and enhance patient care. Healthcare systems and facilities emphasize having readily available, portable, and versatile imaging tools like ultrasound transducers to respond to future health emergencies. In conclusion, the COVID-19 pandemic had short-term disruptions and long-term transformative effects on the market.
Market Growth Factors
Advanced medical equipment investment
Increased healthcare spending is a significant driver behind the growing demand for ultrasound transducers. Healthcare spending encompasses investments made by governments, healthcare institutions, insurers, and individuals to provide and access healthcare services. Higher healthcare spending allows healthcare institutions and facilities to allocate budgets for procuring advanced medical equipment, including ultrasound machines and transducers. These investments aim to modernize healthcare infrastructure and improve the quality of care provided. Increased healthcare spending is directed toward maternal and child healthcare services, where ultrasound is a fundamental tool for prenatal care, monitoring fetal development, and assessing maternal health. This focus on women's and children's health will drive demand.
Growing awareness of ultrasound imaging
The growing awareness of the benefits of ultrasound imaging has led to more frequent and diverse clinical applications of ultrasound and has also played a pivotal role in shaping patient care and medical decision-making. Non-invasiveness and safety are two key attributes that make ultrasound transducers a preferred diagnostic tool in healthcare. These qualities contribute to the widespread adoption and patient acceptance of ultrasound imaging. Ultrasound imaging is entirely non-invasive, meaning it does not require the insertion of instruments or the use of ionizing radiation. This non-invasive nature eliminates the need for surgical incisions, reducing the associated risks and complications. Ultrasound does not require using contrast agents that can trigger allergic reactions in some individuals. This enhances safety, especially for patients with known allergies to contrast materials. All these will significantly drive the expansion of market in the coming years.
Market Restraining Factors
High upfront costs associated with advanced transducers
Developing regions often have limited financial resources and lower per capita income than developed countries. High upfront costs for advanced ultrasound equipment can strain healthcare budgets and make it difficult for healthcare institutions to invest in such technology. Healthcare infrastructure in developing regions may be underdeveloped or inadequately equipped. Allocating a significant part of the budget to expensive imaging equipment may be seen as a trade-off against other pressing healthcare priorities. Developing regions may have concerns about the long-term sustainability of expensive equipment, including the availability of spare parts and technical support, which can create reluctance to invest in advanced technology with high upfront costs. These elements will make it difficult for the ultrasonic transducer market to expand in the coming years.
Product Type Outlook
Based on product type, the market is divided into linear, convex, phased array, endocavitary, CW doppler, and others. The phased array segment procured a noticeable revenue share in the market in 2022. Phased array transducers are essential in cardiac imaging, particularly for echocardiography. Their ability to electronically steer the ultrasound beam allows for precise visualization of cardiac structures and real-time assessment of heart function. With the growing incidences of cardiovascular diseases (CVD), the demand for cardiac ultrasound has grown significantly. Vascular ultrasound relies on phased array transducers to visualize blood vessels, including arteries and veins.
End Use Outlook
By end use, the market is segmented into hospital, clinics, diagnostic center, and ambulatory surgery centers (ASCs). In 2022, the clinic segment acquired a substantial revenue share in the market. Clinics emphasize preventive medicine and health screenings. Ultrasound transducers play a vital role in preventative care by enabling screenings for conditions like breast cancer, thyroid disorders, and abdominal issues, allowing for early detection and intervention. Clinicians in outpatient settings increasingly adopt point-of-care ultrasound (POCUS) to enhance patient care.
Application Outlook
On the basis of application, the market is segmented into cardiovascular, general imaging, musculoskeletal, OB/GYN, vascular, and others. The OB/GYN segment acquired a significant revenue share in the market in 2022. OB/GYN ultrasound transducers are instrumental in prenatal care, allowing healthcare providers to monitor fetal development throughout pregnancy. They assess fetal growth, detect anomalies, determine the baby's position, and evaluate the placenta. Expectant parents rely on ultrasound scans for visualizing and bonding with their unborn child. As maternal age at childbirth increases, the risk of certain complications also rises. High-risk pregnancies often require more frequent and advanced prenatal monitoring, including ultrasound examinations.
Regional Outlook
Based on region, the market is divided into North America, Europe, Asia Pacific, and LAMEA. The North America segment recorded the highest revenue share in the market in 2022. North America boasts advanced healthcare infrastructure, including state-of-the-art medical facilities, hospitals, clinics, and diagnostic centers. This infrastructure creates a robust demand for advanced medical technologies like ultrasound transducers to support high-quality patient care. The region has a relatively high prevalence of chronic diseases, such as cardiovascular conditions, diabetes mellitus, and obesity. Ultrasound transducers are essential for diagnosing, monitoring, and managing these chronic illnesses, contributing to their growing demand. All these factors will assist in expanding the North America segment in the future.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include GE HealthCare Technologies, Inc., Siemens Healthineers AG (Siemens AG), FUJIFILM Sonosite, Inc. (Fujifilm Holdings Corporation), Canon, Inc. (Canon Medical Systems Corporation), Hitachi, Ltd. (Hitachi Healthcare), SonoScape Medical Corp., Koninklijke Philips N.V., Samsung Electronics Co., Ltd. (Samsung Group) (Samsung Medison Co., Ltd.), Shenzhen Mindray Bio-Medical Electronics Co., Ltd. and Esaote SpA
Recent Strategies Deployed in Ultrasound Transducer Market
Product Launches and Product Expansions
Jan-2023: FUJIFILM Sonosite, Inc. revealed the Sonosite PX ultrasound system. The newest version of Sonosite POCUS, called Sonosite PX, offers the highest level of visual quality ever seen in a Sonosite system, as well as a number of features that help with workflow efficiency and a flexible form factor. The device offers a novel and adjustable work surface that can be employed in a horizontal or vertical position depending on the situational needs of the exam in order to increase clinician ergonomics and productivity.
Nov-2022: Philips released the compact 5000 series, a new compact ultrasound system. The Compact 5000 series make it easier for more patients to have their ultrasound exams done correctly the first time around because of its portability and versatility without sacrificing image quality or performance.
Sep-2022: FUJIFILM Sonosite Inc. launched Sonosite LX system in several European countries. Following this launch, the company also released T8-3 transoesophageal transducer and Cardiac Resuscitation exam type to support clinicians in using transoesophageal ultrasound at the point of care, both of which are created to be used with the Sonosite LX and Sonosite PX.
Jul-2022: GE HealthCare Technologies, Inc. released Voluson Expert 22, the most advanced ultrasound yet. The launched product would produce the best quality images and would provide greater flexibility in imaging functions.
Jun-2022: Mindray unveiled TEX20 Series, best-in-class Point of Care ultrasound system. With its patient-centred information solution, extraordinary image clarity, clinically oriented workflow, smart tools, and intelligent design, this ground-breaking point of care system, the TEX20 Series, dramatically alters the conventional perspective of POC ultrasonography from its predecessors. It offers all the details needed to make decisions for follow-up and quality control.
May-2021: Esaote launched the new MyLab X9 ultrasound system. This system provides the top level of image quality and data processing capability, utilizing the new technological solutions to explore the latest frontiers of ultrasound imaging.
Mar-2021: GE Healthcare today unveiled Venue Fit, a streamlined and compact POCUS system, alongside an industry-first AI offering for cardiac imaging. The Venue Fit is the smallest system in the Venue Family from GE Healthcare, with a tiny footprint designed to fit in confined places, an easy-to-clean touchscreen, and straightforward scanning tools. The new Venue Fit ultrasound device enables healthcare professionals who work in constrained areas to get immediate imaging insights.
Mar-2021: GE Healthcare released Vscan Air, hand-held ultrasound device. The new product is completely wireless, links to a smartphone app, and enables patients to safely access the images. Trained healthcare professionals can use the gadget to immediately test blood flow, and gallbladder illness, and analyze and monitor Covid-19 through a lung exam.
Mergers & Acquisition
Jul-2023: Shenzhen Mindray Bio-Medical Electronics Co., Ltd. announced an agreement to acquire a 75% equity interest in DiaSys Diagnostic Systems GmbH. Through this acquisition, Mindray would significantly strengthen its international supply chain infrastructure and assist the expansion of our IVD business into medium- to large-sized customer sectors. Both companies will work together to realize synergies and increase value for our customers.
Sep-2021: GE Healthcare completed the acquisition of BK Medical, a company that offers ultrasound technology. The acquisition would help GE Healthcare expand its ultrasound offerings into surgical visualization and fuel the growth in precision health.
Partnerships, Collaborations & Agreements
Sep-2021: GE Healthcare joined hands with UltraSight, a digital health pioneer transforming cardiac imaging through the power of AI. The images of an astronaut's heart in microgravity would be captured using the real-time AI guidance software of UltraSight and the portable GE Vscan AirTM, a high-performance, wireless pocket-sized color ultrasound from GE Healthcare.
Jan-2021: Hitachi entered into an agreement with Olympus Corporation, a manufacturer of optics and reprography products. With this agreement, the company aimed to offer better diagnostic and treatment to patients and healthcare professionals.
Market Segments covered in the Report:
By Product Type (Volume, Thousand Units, USD Million, 2019-2030)
By End Use (Volume, Thousand Units, USD Million, 2019-2030)
By Application (Volume, Thousand Units, USD Million, 2019-2030)
By Geography (Volume, Thousand Units, USD Million, 2019-2030)
Companies Profiled
Unique Offerings from KBV Research